AZTA - Azenta to acquire Barkey Holding for EUR 80M

Azenta (NASDAQ:AZTA) to acquire Germany based Barkey Holding and its subsidiaries for total cash consideration of ~EUR 80M. Barkey has over four decades of expertise in the automated thawing of plasma, blood and stem cells and has more recently focused on cell and gene therapy applications.  Barkey's plasmatherm product is an automated cell thawing device approved by the FDA as a medical device for clinical use. The deal is expected to close in early July upon satisfaction of customary closing conditions. Co-owners Chris Barkey and Thomas Barkey, and COO Armin Nowack, who have led the company for over 20 years, will join Azenta and continue to lead the business as part of the Life Sciences Products segment.  The company expects the deal to be accretive to non-GAAP earnings immediately and to become accretive to GAAP-based earnings within the first year of ownership.

For further details see:

Azenta to acquire Barkey Holding for EUR 80M